RxDoctor Payments Data

Baron Williamson, MD

Ophthalmology · Zachary, LANPI 1336145606

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 116 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. Alcon accounts for 73.2% of it on its own, with 13 other manufacturers making up the rest. Reporting peaked in 2021 at $1,454 and has fallen 55.7% since, to $644 in 2025.

$6,587in general payments, 2019–2025

Across 116 payments — averaging $56.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Alcon$5K
  • Glaukos Corporation$476
  • AbbVie$292
  • NEW World Medical,inc.$280
  • Johnson & Johnson Surgical Vision, Inc.$263
  • Regeneron Healthcare Solutions, Inc.$125
  • plus $332 from 8 others

What the payments were for

  • Food & beverage$6,587100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,587 in reported general payments places this provider in the 85th percentile of 286 ophthalmology providers in Louisiana.

See all ophthalmology providers in Louisiana

Medicare billing

Part B allowed, 2024
$477,459
Medicare patients
663
Services billed
3,311

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Prednisolone Acetate1,180$59,251
MoxifloxacinMoxifloxacin Hcl1,078$24,280
Ketorolac Tromethamine985$20,490
Cyclosporine13$5,178
Ofloxacin48$668
Brimonidine Tartrate28$396
Azithromycin112$325
Minocycline Hcl17$315
Polymyxin B Sul-TrimethoprimPolymyxin B Sulf/Trimethoprim32$209
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen80$201
Latanoprost31$156
Tobramycin32$153
Cephalexin12$99

Paid to pharmacies, not to this prescriber.

Other ophthalmology in Zachary

See the full list for Louisiana

Where these figures come from

Is this you, or does something look wrong? →